V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10461958 | 10035016 | 1.78 | 60 | Adjuvant (A) | 2017-07-30 | 2017-08-12 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101488313 |
| 10461959 | 10035017 | 1.79 | 82.8 | Neo-adjuvant (N) | 2016-12-17 | 2016-12-17 | Capecitabine + Oxaliplatin 21day | 02 | Y | PEMBROLIZUMAB | 101207083 |
| 10461988 | 10035018 | 1.72 | 69.8 | Adjuvant (A) | 2019-09-04 | 2019-09-04 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100332912 |
| 10461989 | 10035019 | 1.59 | 159.9 | null | 2021-11-16 | 2021-11-16 | Capecitabine + Oxaliplatin 21day | 02 | null | PEMBROLIZUMAB | 101154582 |
| 10461991 | 10035020 | 1.75 | 89.66 | Palliative (P) | 2017-06-14 | 2017-06-26 | Rituximab | 02 | N | RITUXIMAB | 101498994 |
| 10462001 | 10035021 | 1.58 | 77.4 | Curative (C) | 2021-05-28 | 2021-06-14 | CAPECITABINE + RT | 02 | N | CAPECITABINE | 101052814 |
| 10462003 | 10035022 | 1.57 | 0 | null | 2020-04-25 | 2020-05-01 | CHOP R | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100675513 |
| 10462015 | 10035023 | 1.66 | 73 | Curative (C) | 2019-08-02 | 2019-08-19 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 101363095 |
| 10462030 | 10035024 | 0 | null | Curative (C) | 2020-05-25 | 2020-05-25 | Rituximab | 02 | N | RITUXIMAB | 100049218 |
| 10462077 | 10035025 | 1.72 | 66.5 | Palliative (P) | 2022-01-07 | 2022-01-19 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101434371 |
| 10462085 | 10035026 | 1.53 | 60 | Curative (C) | 2021-07-11 | 2021-07-14 | Capecitabine + Oxaliplatin 21day | 02 | null | RITUXIMAB | 100241570 |
| 10462106 | 10035027 | 1.64 | 60 | 03 | 2015-01-24 | 2015-02-10 | IBRUTINIB | 02 | N | IBRUTINIB | 100801918 |
| 10462142 | 10035028 | 1.69 | 92.18 | null | 2021-11-21 | 2021-11-21 | Rituximab | 02 | null | RITUXIMAB | 101149724 |
| 10462163 | 10035029 | 1.57 | 55.3 | 03 | 2019-03-24 | 2019-04-09 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100934686 |
| 10462251 | 10035030 | 1.74 | 127 | null | null | 2017-02-14 | Rituximab | 02 | null | RITUXIMAB | 100883910 |
| 10462252 | 10035031 | 1.77 | 45.1 | Palliative (P) | 2019-11-29 | 2019-12-08 | Capecitabine + Oxaliplatin 21day | 02 | N | DOCETAXEL | 101575944 |
| 10462278 | 10035032 | 1.68 | 74.5 | Palliative (P) | 2019-02-15 | 2019-02-22 | CHOP R - 21 days | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101798608 |
| 10462283 | 10035033 | 1.72 | 67.7 | Adjuvant (A) | 2016-09-12 | 2016-09-19 | Rituximab | 02 | N | RITUXIMAB | 101347642 |
| 10462288 | 10035034 | 1.57 | 68 | null | 2021-08-01 | 2021-08-15 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101297019 |
| 10462292 | 10035035 | 1.74 | 56.6 | Adjuvant (A) | 2018-01-23 | 2018-02-05 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101319363 |
| 10462297 | 10035036 | 1.7 | 72.2 | Disease modification (D) | 2018-05-12 | 2018-05-12 | Docetaxel 75mg/m2 (21 day) | 02 | Y | DOCETAXEL | 100232660 |
| 10462302 | 10035037 | 1.7 | 57.4 | null | 2022-01-13 | 2022-01-24 | Docetaxel | 02 | null | DOCETAXEL | 100059674 |
| 10462304 | 10035038 | 1.67 | 71.7 | Palliative (P) | 2020-07-17 | 2020-07-31 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101074268 |
| 10462308 | 10035039 | 1.67 | 68.4 | Adjuvant (A) | 2017-05-23 | 2017-05-23 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101626062 |
| 10462310 | 10035040 | 1.54 | 64.8 | Adjuvant (A) | 2016-08-17 | 2016-08-17 | IBRUTINIB | 02 | N | IBRUTINIB | 101360439 |
| 10462321 | 10035041 | 1.64 | 65.2 | null | 2020-12-11 | 2020-12-11 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101063283 |
| 10462332 | 10035042 | 1.67 | 83 | null | 2019-10-04 | 2019-10-22 | Docetaxel | 02 | N | DOCETAXEL | 100725853 |
| 10462358 | 10035043 | 1.63 | 66.7 | Not known (9) | 2017-10-03 | 2017-10-26 | Capecitabine + Oxaliplatin 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101734910 |
| 10462369 | 10035044 | 1.69 | 93.2 | Curative (C) | 2018-10-17 | 2018-10-27 | CAPECITABINE + OXALIPLATIN | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100965868 |
| 10462370 | 10035045 | 0 | 86 | 03 | 2019-05-23 | 2019-06-07 | CAPECITABINE + OXALIPLATIN | N | N | IBRUTINIB | 101006062 |
| 10462372 | 10035046 | 1.7 | 80.2 | 03 | 2020-08-29 | 2020-09-19 | CAPECITABINE + OXALIPLATIN | 02 | N | DOCETAXEL | 100237833 |
| 10462388 | 10035047 | 1.66 | 71 | Curative (C) | 2019-08-17 | 2019-08-24 | IBRUTINIB | 02 | Y | IBRUTINIB | 100704246 |
| 10462420 | 10035048 | 1.9 | 56.6 | Adjuvant (A) | 2019-08-06 | 2019-08-08 | Capecitabine + Oxaliplatin 21day | 2 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100461323 |
| 10462430 | 10035049 | 1.59 | 80 | Palliative (P) | 2019-05-02 | 2019-05-13 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100341704 |
| 10462438 | 10035050 | null | 109 | Palliative (P) | null | 2017-06-07 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101019373 |
| 10462473 | 10035051 | 1.72 | 72.8 | null | 2021-09-29 | 2021-09-30 | Capecitabine | 02 | null | CAPECITABINE | 101624206 |
| 10462475 | 10035052 | 1.72 | 82.85 | Palliative (P) | 2021-11-22 | 2021-11-26 | CHOP R | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101335113 |
| 10462518 | 10035053 | 1.67 | 71.4 | 03 | null | 2017-10-31 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 101519421 |
| 10462524 | 10035054 | 1.58 | 68 | Curative (C) | 2017-09-07 | 2017-09-17 | CAPECITABINE + RT | 02 | N | CAPECITABINE | 101514233 |
| 10462566 | 10035055 | 1.57 | 70.5 | null | 2021-08-14 | 2021-09-03 | Capecitabine | 02 | null | CAPECITABINE | 101596318 |
| 10462570 | 10035056 | 1.7 | 90.3 | Palliative (P) | 2017-02-18 | 2017-02-18 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101147930 |
| 10462581 | 10035057 | 1.66 | 85.9 | Palliative (P) | 2018-02-10 | 2018-02-10 | CHOP R - 21 days | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100030791 |
| 10462592 | 10035058 | 1.64 | 60.1 | Palliative (P) | 2018-04-23 | 2018-04-23 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101035972 |
| 10462600 | 10035059 | 1.67 | 88.5 | Curative (C) | 2017-03-14 | 2017-03-22 | Rituximab | 02 | N | RITUXIMAB | 101516786 |
| 10462606 | 10035060 | 1.75 | 68.9 | Palliative (P) | 2018-09-17 | 2018-09-29 | CAPECITABINE + OXALIPLATIN | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101298001 |
| 10462636 | 10035061 | 1.63 | 72 | null | 2022-01-04 | 2022-01-17 | Capecitabine | 02 | null | CAPECITABINE | 101267465 |
| 10462643 | 10035062 | 1.51 | 56 | Palliative (P) | 2020-07-05 | 2020-07-07 | Capecitabine + Oxaliplatin 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100135846 |
| 10462671 | 10035063 | 1.72 | 76 | null | 2019-11-04 | 2019-11-11 | CAPECITABINE + OXALIPLATIN | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100187938 |
| 10462673 | 10035064 | 1.73 | 97.2 | Adjuvant (A) | 2019-06-04 | 2019-06-13 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE | 100487036 |
| 10462678 | 10035065 | 1.83 | 62.8 | Palliative (P) | 2019-10-31 | 2019-11-20 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101319759 |